Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 6
2013 3
2014 4
2015 4
2016 1
2017 4
2018 4
2019 1
2020 3
2021 6
2022 5
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Lung function at three months after hospitalization due to COVID‑19 pneumonia: Comparison of alpha, delta and omicron variant predominance periods.
Georgakopoulou VE, Makrodimitri S, Gkoufa A, Apostolidi E, Provatas S, Papalexis P, Spandidos DA, Lempesis IG, Gamaletsou MN, Sipsas NV. Georgakopoulou VE, et al. Among authors: gamaletsou mn. Exp Ther Med. 2024 Jan 5;27(2):83. doi: 10.3892/etm.2024.12372. eCollection 2024 Feb. Exp Ther Med. 2024. PMID: 38274344 Free PMC article.
Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study.
Georgakopoulou VE, Gkoufa A, Makrodimitri S, Basoulis D, Tsakanikas A, Karamanakos G, Mastrogianni E, Voutsinas PM, Spandidos DA, Papageorgiou CV, Gamaletsou MN, Sipsas NV. Georgakopoulou VE, et al. Among authors: gamaletsou mn. Exp Ther Med. 2023 Aug 9;26(4):462. doi: 10.3892/etm.2023.12161. eCollection 2023 Oct. Exp Ther Med. 2023. PMID: 37664680 Free PMC article.
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.
Basoulis D, Tsakanikas A, Gkoufa A, Bitsani A, Karamanakos G, Mastrogianni E, Georgakopoulou VE, Makrodimitri S, Voutsinas PM, Lamprou P, Kontos A, Tsiakas S, Gamaletsou MN, Marinaki S, Sipsas NV. Basoulis D, et al. Among authors: gamaletsou mn. Viruses. 2023 Jul 7;15(7):1515. doi: 10.3390/v15071515. Viruses. 2023. PMID: 37515201 Free PMC article.
Bone Marrow Iron Stores Are Not Associated with Increased Risk for Invasive Fungal Infections in Patients with Newly Diagnosed Acute Leukemia or Myelodysplastic Syndrome in Transformation: Is There a Relationship?
Apostolidi EA, Gamaletsou MN, Arapaki M, Asimakopoulos JV, Diamantopoulos P, Zafeiratou S, Kofteridis D, Pagoni M, Kotsopoulou M, Voulgarelis M, Sipsas NV. Apostolidi EA, et al. Among authors: gamaletsou mn. J Fungi (Basel). 2023 Jul 14;9(7):748. doi: 10.3390/jof9070748. J Fungi (Basel). 2023. PMID: 37504736 Free PMC article.
Effectiveness of a Self-Decontaminating Coating Containing Usnic Acid in Reducing Environmental Microbial Load in Tertiary-Care Hospitals.
Maltezou HC, Papamichalopoulos N, Horefti E, Tseroni M, Karapanou A, Gamaletsou MN, Veneti L, Ioannidis A, Panagiotou M, Dimitroulia E, Vasilogiannakopoulos A, Angelakis E, Chatzipanagiotou S, Sipsas NV. Maltezou HC, et al. Among authors: gamaletsou mn. Int J Environ Res Public Health. 2023 Apr 7;20(8):5434. doi: 10.3390/ijerph20085434. Int J Environ Res Public Health. 2023. PMID: 37107716 Free PMC article.
Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece.
Maltezou HC, Basoulis D, Bonelis K, Gamaletsou MN, Giannouchos TV, Karantoni E, Karapanou Α, Kounouklas K, Livanou ME, Zotou M, Rapti V, Stamou P, Loulakis D, Souliotis K, Chini M, Panagopoulos P, Poulakou G, Syrigos KN, Hatzigeorgiou D, Sipsas NV. Maltezou HC, et al. Among authors: gamaletsou mn. Vaccine. 2023 Mar 31;41(14):2343-2348. doi: 10.1016/j.vaccine.2023.01.067. Epub 2023 Feb 2. Vaccine. 2023. PMID: 36740558 Free PMC article.
Osteoarticular Mycoses.
Gamaletsou MN, Rammaert B, Brause B, Bueno MA, Dadwal SS, Henry MW, Katragkou A, Kontoyiannis DP, McCarthy MW, Miller AO, Moriyama B, Pana ZD, Petraitiene R, Petraitis V, Roilides E, Sarkis JP, Simitsopoulou M, Sipsas NV, Taj-Aldeen SJ, Zeller V, Lortholary O, Walsh TJ; International Consortium for Osteoarticular Mycoses. Gamaletsou MN, et al. Clin Microbiol Rev. 2022 Dec 21;35(4):e0008619. doi: 10.1128/cmr.00086-19. Epub 2022 Nov 30. Clin Microbiol Rev. 2022. PMID: 36448782 Free PMC article. Review.
Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study.
Maltezou HC, Gamaletsou MN, Koukou DM, Giannouchos TV, Sourri F, Syrimi N, Karapanou A, Lemonakis N, Peskelidou E, Papanastasiou K, Panagopoulos P, Souliotis K, Lourida A, Hatzigeorgiou D, Sipsas NV. Maltezou HC, et al. Among authors: gamaletsou mn. Vaccine. 2022 Dec 12;40(52):7660-7666. doi: 10.1016/j.vaccine.2022.10.049. Epub 2022 Oct 26. Vaccine. 2022. PMID: 36372669 Free PMC article.
Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece.
Maltezou HC, Tseroni M, Drositis I, Gamaletsou MN, Koukou DM, Bolikas E, Peskelidou E, Daflos C, Panagiotaki E, Ledda C, Pavli A, Moussas N, Kontogianni S, Svarna E, Ploumidis M, Spyrou A, Chini M, Adamis G, Lourida A, Hatzigeorgiou D, Gargalianos P, Syrogiannopoulos G, Sipsas NV. Maltezou HC, et al. Among authors: gamaletsou mn. Expert Rev Vaccines. 2022 Jun;21(6):853-859. doi: 10.1080/14760584.2022.2063118. Epub 2022 Apr 13. Expert Rev Vaccines. 2022. PMID: 35382665
42 results